189 related articles for article (PubMed ID: 12113133)
41. [Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma)].
Takahashi T; Suzumiya J
Nihon Rinsho; 2014 Mar; 72(3):493-8. PubMed ID: 24724410
[TBL] [Abstract][Full Text] [Related]
42. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
43. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
[TBL] [Abstract][Full Text] [Related]
44. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
[TBL] [Abstract][Full Text] [Related]
45. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
[TBL] [Abstract][Full Text] [Related]
46. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
Ferrucci PF; Zucca E
Br J Haematol; 2007 Feb; 136(4):521-38. PubMed ID: 17156403
[TBL] [Abstract][Full Text] [Related]
47. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
48. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Desar IM; Keuter M; Raemaekers JM; Jansen JB; van Krieken JH; van der Meer JW
Neth J Med; 2006 May; 64(5):136-40. PubMed ID: 16702611
[TBL] [Abstract][Full Text] [Related]
49. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
[TBL] [Abstract][Full Text] [Related]
50. [Helicobacter pylori and malignant diseases of the stomach].
Prskalo M; Sabarić B; Tićak M; Skurla B; Dominis M; Dzebro S; Gasparov S; Colić-Cvrlje V; Naumovski-Mihalić S; Filipec T; Papa B; Ljubanović D; Presecki V; Katicić M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():57-60. PubMed ID: 12592819
[TBL] [Abstract][Full Text] [Related]
51. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
Iwai H; Nakamichi N; Nakae K; Konishi M; Inaba M; Hoshino S; Baba S; Amakawa R
Laryngoscope; 2009 Aug; 119(8):1491-4. PubMed ID: 19504556
[TBL] [Abstract][Full Text] [Related]
52. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.
O'Rourke JL; Dixon MF; Jack A; Enno A; Lee A
J Pathol; 2004 Aug; 203(4):896-903. PubMed ID: 15258991
[TBL] [Abstract][Full Text] [Related]
53. [MALT stomach lymphoma: is there a standardized therapy?].
Fischbach W
Z Gastroenterol; 1998 Dec; 36(12):1099-102. PubMed ID: 10025061
[No Abstract] [Full Text] [Related]
54. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
55. Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma.
Sjö NC; Foegh P; Juhl BR; Nilsson HO; Prause JU; Ralfkiaer E; Wadström T; Heegaard S
Ophthalmology; 2007 Jan; 114(1):182-6. PubMed ID: 17198854
[TBL] [Abstract][Full Text] [Related]
56. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
[TBL] [Abstract][Full Text] [Related]
57. State-of-the-art therapeutics: marginal-zone lymphoma.
Bertoni F; Zucca E
J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
[TBL] [Abstract][Full Text] [Related]
58. Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori.
Takenaka R; Yokota K; Mizuno M; Okada H; Toyokawa T; Yamasaki R; Yoshino T; Sugiyama T; Asaka M; Shiratori Y; Oguma K
Helicobacter; 2004 Jun; 9(3):194-200. PubMed ID: 15165254
[TBL] [Abstract][Full Text] [Related]
59. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori infection and gastric MALT lymphoma.
Lehours P; Mégraud F
Rocz Akad Med Bialymst; 2005; 50():54-61. PubMed ID: 16358940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
